InvestorsHub Logo
Followers 4
Posts 260
Boards Moderated 0
Alias Born 09/05/2013

Re: eicoman post# 20639

Friday, 10/31/2014 1:07:45 PM

Friday, October 31, 2014 1:07:45 PM

Post# of 30352
Eman, if APRI BOD and Pascoe were to show confidence of putting Femprox as one their key pipeline products, continue to communicate the value of Femprox as part of corporate updates/investors/analysts briefings, then I would agree with you. Right now, Femprox, after 8+ years on the back-burner (since last China trials), has been again relegated by APRI mgmt to a 'legacy product' and all mention of it has been removed from the website, presentations, etc... except for one small mention in Morton's business development - looking for partners.

Your messaging and hope does NOT align with what APRI mgmt is communicating currently. Wish APRI BOD and Pascoe would clarify for all investors, and not keep dangling the Femprox carrot as and when they feel like to fill a gap in their development pipeline when something drops out. Mgmt is NOT transparent with investors re Femprox! Atleast, PTN and Sprout are bravely fighting the war... and supporting EvenTheScore and FDA fight... where is APRI??? I guess lurking in the background (ya, they sent 2 reps, but so what?) by removing all references to Femprox from their website???

Sign up to ask APRI BOD, Pascoe and mgmt the hard questions on Femprox, that's what all investors should be doing!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News